BrightGene Bio-Medical Fair Value
68
The fair market value of 688166.SS stock is 32.32 CNY. Relative to the market price of 33.69 CNY BrightGene Bio-Medical is overvalued by 4.1%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
BrightGene Bio-Medical Valuation
Current 688166.SS share ticker price is 33.69 CNY.
The fair value level of 32.32 CNY can be considered as an effective entry point for long-term investors to start investing in 688166.SS stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 4% higher its fair value
Current price is 36% higher its minimum value
Current price is 124% lower its maximum value
Market price:
688166.SS stock is overvalued
It means the current price may concern as a Risky Entry Point
BrightGene Bio-Medical Technology Co Ltd Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
136.49
2
Median P/E over 5 years
58.41
3
Minimum P/E over 5 years
39.19
4
Earning per share (last 12 months)
0.55 CNY
Maximum value
1
x
4
=
75.53 CNY
Fair value
2
x
4
=
32.32 CNY
Minimum value
3
x
4
=
21.69 CNY
BrightGene Bio-Medical Technology Co Ltd price metrics
1.5
Annual return (geometric mean)
54.6
Risk (standard deviation) of returns
β
1.9
Beta (volatility compared to market)